Nations that lead in clinical trials get earlier access to breakthrough therapies, shape global regulatory norms, and ...

In the past, coverage for clinical trials has not been uniformly provided under employer-sponsored plans. Today, the ACA has opened the door for more plan participants to take part in a wider array of ...

Dr. Anil Diwan, the Company's President, and Executive Chairman, is currently visiting with various expert professionals with the objective of developing a Phase II clinical trial plan and ...

A successful Phase II clinical trial is expected to provide results demonstrating a strong effectiveness of NV-387 against different human pathogenic viruses, consistent with the strong ...